ஜர்னல் ஆஃப் வுமன்ஸ் ஹெல்த் கேர்
திறந்த அணுகல்

சுருக்கம்

Risk of Abruption Placenta in Women with Preeclampsia Undergoing Labour Induction with Misoprostol

Mamour Gueye , Ndiaye-Gueye Mame Diarra, Cisse Mamadou lamine, Gaye Alioune and Moreau Jean Charles

Objectives: To evaluate the risk of abruption placentae in women with preeclampsia undergoing labour induction with misoprostol.

Patients and Methods: This is a retrospective, descriptive and analytical study of 1.136 cases of labour induction with misoprostol performed vaginally at “Roi Baudouin” Health Centre in Dakar suburbs from 2009 to 2011. For each patient, were collected and analysed sociodemographic data, pregnancy and birth characteristics. The population was divided into 2 groups. The first group concerned patients who had preeclampsia and the second group, patients undergoing induction of labour for another indication. In each group, rate of abruption placentae was analysed. Data were entered and analysed using SPSS 17.0 software.

Results: Over 3 years, 1.136 patients underwent labour induction with misoprostol on 16.125 births (7%). The average age of patients was 27.2 years, the mean gravidity 2 and the average parity 2.47. Labour induction was performed for preeclampsia in 30.1% of cases. For 94.5% of patients, 50 μg was used as double (100 μg) was used in 63 patients (4.5%). Abruption placenta occurred in 4% of cases in patients with preeclampsia and in 0.3% of cases in patients who underwent induction for another indication (p <0.0001). 22 intrapartum deaths (2.1%) were recorded and 20 early neonatal deaths (2%). The transfer rate in neonates was 14.8%. Neonatal complications were more frequent in the preeclampsia group.

Conclusion: Induction of labour with misoprostol on preeclampsia is associated with a high risk of abruption placentae, low Apgar score at the 5th minute and intrapartum and early neonatal deaths.